Pastor MC, et al. - Researchers analyzed data from their center’s hemodialysis electronic database during a 10-year period to determine hemodialysis-dependent life expectancy by age of the patient at dialysis initiation and to compare this with the durability of the various hemodialysis access options. Observations suggest an increased median life expectancy among patients who use an arteriovenous fistula (AVF). These patients had a greater life expectancy than the secondary patency of arteriovenous grafts and central venous catheters (CVCs). Hence AVF was supported as the best hemodialysis option in this subset of patients.